Prebrali smo o tožbi zaradi laboratorijskih testov za zdravila, zdravilo za mielom Bristol in še več.

QuartzNeodvisenSredinaDejstva 85Objektivnost 80pred 10 dnevi

Ameriško pritožbeno sodišče je soglasno odločilo, da ima banka UMB pravico zastopati nekdanje delničarje Celgene v tožbi v višini 6,7 milijarde dolarjev proti podjetju Bristol Myers Squibb, čeprav je bila v njenem imenovanju storjena postopkovna napaka.

Ocena pristranskosti (Sredina): Članek predstavlja pravno odločbo kot dejansko posodobitev, ne da bi očitno naklonil nobeni strani spora. Osredotočen je na postopkovne vidike primera in ne zavzema jasnega stališča o širših posledicah farmacevtske regulacije ali odgovornosti podjetij.

Zakaj dejstva (85): The article reports on a legal decision where an appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb. It mentions the ruling by a unanimous 3-judge panel regarding standing for UMB Bank to represent former Celgene shareholders. The information aligns with typical legal reportin

Zakaj objektivnost (80): The tone remains neutral, presenting the legal outcome without overt bias. The article focuses on the court's decision and the procedural aspects without injecting personal opinion or emotional language. However, the phrasing 'revived a $6.7 billion lawsuit' may subtly emphasize the significance of

STAT NewsNeodvisenSredinaDejstva 50Objektivnost 30pred 9 dnevi

Članek obravnava dve glavni temi. Prvič, ameriška uprava za hrano in zdravila (FDA) je odobrila peroralno zdravljenje naprednega multiplega mieloma, ki ga je razvil Bristol Myers Squibb, znan kot Zenbexus. To označuje uvedbo novega razreda zdravil za raka krvi in prvo zdravilo, odobreno z uporabo bolj občutljive metode merjenja remisije.

Ocena pristranskosti (Sredina): V članku so predstavljene informacije o odobritvi zdravil FDA in pravni spor, ki vključuje veliko farmacevtsko družbo.

Zakaj dejstva (50): The article mentions FDA approval of a Bristol Myers Squibb drug for multiple myeloma and a court ruling regarding a $6.7 billion lawsuit against the company. However, the content is largely obfuscated by unrelated text about weekend plans and other non-news topics. The factual claims are present bu

Zakaj objektivnost (30): The tone is informal and recreational, with a focus on weekend activities rather than news. The article does not present the legal ruling or medical approval in a neutral manner, instead embedding them within a disjointed narrative that lacks journalistic objectivity. The writing style suggests a ca